Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort
Adrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Isabell von Loga, Raphael Micheroli, Burkhard Möller, Andrea Rubbert‐Roth, Michael Andor, René Bräm, Angela Müller, Diana Dan, Diego Kyburz, Oliver Distler, Almut Scherer, Axel Finckh
Topics & Concepts
MedicinePsoriatic arthritisRheumatoid arthritisCohortAnkylosing spondylitisRheumatologyInternal medicinePandemicDiseasePhysical therapyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Spondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and TherapiesCOVID-19 and healthcare impacts